Humans with metabolic diseases have increased plasma concentrations of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, C-reactive protein and other inflammatory mediators (Dandona et al., 2005; Hotamisligil, 2006; Esser et al., 2014). This evidence concerns the gene TNF and metabolic disease.